EC BORDEN - Annals of Internal Medicine, 1979 - Am Coll Physicians Interferons, cell glycoproteins synthesized in response to viral infections and
various nonviral inducers, have proved therapeutically effective for viral
infections in experimental models and in humans. Current evidence suggests ... Cited by 81 - Related articles - All 3 versions
GR Pape, MR Hadam, J Eisenburg, G … - Cancer Immunology, Immunotherapy, 1981 - Springer Summary. Short- and long-term effects of IV admin- istration of human fibroblast
interferon (HFIF) on natural cytotoxicity was studied in patients with
HBsAg-positive chronic active hepatitis. Short-term kinetics demonstrated a ... Cited by 24 - Related articles
TC Merigan, K Sikora, JH Breeden, R Levy, … - The New England journal of medicine, 1978 - ncbi.nlm.nih.gov 1: N Engl J Med. 1978 Dec 28;299(26):1449-53. Preliminary observations on the
effect of human leukocyte interferon in non-Hodgkin's lymphoma. ... Cited by 188 - Related articles - All 2 versions
CA Spina, JL Fahey, D Durkos-Smith, F Dorey … - Journal of biological response modifiers, 1983 - ncbi.nlm.nih.gov Lymphoblast interferon (IFN-alpha) was administered to patients with advanced
stages of cancer in a phase I drug toxicity trial. IFN-alpha was given im twice
daily at 12-h intervals over a 7-day course of therapy in dosages ranging ... Cited by 18 - Related articles
M Krim - Blood, 1980 - Am Soc Hematology . Hematology; all rights reserved Copyright 2007 by The American Society of DC
20036. by the American Society of Hematology, 1900 M St, NW, Suite 200,
Washington Blood (print ISSN 0006-4971, online ISSN 1528-0020), is ... Cited by 40 - Related articles - All 4 versions
- ►aacrjournals.org [PDF] J Laszlo, AT Huang, WD Brenckman, C Jeffs, H … - Cancer Research, 1983 - AACR An extensive Phase I evaluation of human lymphoblastoid interferon has been
completed which, in addition to describing its clinical and pharmacological
effects, emphasized a broad- scale evaluation of the immune response as a ... Cited by 43 - Related articles - All 3 versions
- ►aacrjournals.org [PDF] JR Neefe, JE Sullivan, M Ayoob, E Phillips, … - Cancer Research, 1985 - AACR Thirty patients with metastatic colon or breast cancer were treated with
recombinant a-interferon, clone A, 9 to 50 x 106 units/sq m, im, 3 times weekly
for up to 4 months. Immunolog ical parameters including natural killer ... Cited by 15 - Related articles - All 3 versions
H Blomgren, K Cantell, B Johansson, C … - Acta Med Scand, 1976 - interscience.wiley.com ABSTRACT. The treatment of a case of Hodgkin's disease (lymphocyte predominance,
stage IVB) with exogenous im interferon therapy is described. B symptoms
disappeared, diseased nodes and pulmonary infiltrations decreased in size, ... Cited by 56 - Related articles - All 2 versions
